MENU
VTRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viatris (VTRS) Ownership - Who owns Viatris?

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Profile

Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
30000
Web
https://www.viatris.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
18.96B
P/E Ratio
236.20
Total Cash
1.51B
Projected Growth
1.05
Total Debt
13.63B
Revenue
14.74B
Risk (Beta)
0.99
Dividend Yield
0.03
Total Cash/Share
1.32
Total Debt/Equity
N/A
Revenue/Share
12.64 USD as % of share price
View a ticker or compare two or three
VTRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details
Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
30000
Web
https://www.viatris.com
Who owns Viatris? VTRS symbol Ownership - Tickeron.com